Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.
    Difference
    0.0%
    Check dated 2025-05-14T23:59:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has updated its date references, removing older dates and adding new ones, indicating a refresh of the content. The last update posted label has also been modified to reflect a more current status.
    Difference
    0.6%
    Check dated 2025-05-07T20:31:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T18:43:10.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, particularly the removal of detailed information about a clinical study on pembrolizumab and radiation therapy for Hodgkin lymphoma, while adding a new study design description and a revision note.
    Difference
    44%
    Check dated 2025-04-16T13:15:34.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.
    Difference
    0.1%
    Check dated 2025-04-09T05:52:12.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:00:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.